OncoSec Announces Promotion of Christopher G. Twitty, Ph.D. to Chief Scientific Officer

SAN DIEGO, Dec. 5, 2017 -- (Healthcare Sales & Marketing Network) -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today announced the promotion of Christopher G. Twitty, Ph.D.... Biopharmaceuticals, Oncology, Personnel OncoSec Medical, ImmunoPulse, immunotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news